Tag Archives: Biotechnology

29Oct/25

Nanomedicine Breakthrough Redefines Oncology Drug Delivery

This report focuses on a major shift in the oncology market toward advanced drug delivery systems, specifically nanomedicine. It highlights how poor bioavailability limits the effectiveness of traditional cancer drugs and presents Oncotelic Therapeutics Inc.’s Deciparticle platform as a solution designed to significantly increase drug absorption and reduce toxicity. The article details the platform’s versatility, its clinical momentum with the advancement of Sapu-003 (Deciparticle Everolimus) into human trials, and the projection that the nanomedicine market will surpass $500 billion by 2032, driven by delivery innovation. Continue reading

05Oct/23

Large-scale proteomics in population-based studies from UK and Iceland

n an article revealed today in Nature, scientists from deCODE Genetics, a subsidiary of the pharmaceutical company Amgen, demonstrated how plasma proteomics can contribute to a better understanding of diseases. The study’s focus on the plasma proteome led the team to find associations between various diseases and the levels of specific proteins. “Measuring a great number of proteins in a population-based cohort enables the discovery of circulating biomarkers and the early detection of disease,” says Patrick Sulem, scientist at deCODE genetics and one of the senior authors on the paper. Continue reading

04Nov/22

‘Secrets of Shape-Shifting Proteins Revealed’: Real-time observation of life at the smallest scale, shows how vibrations are used by proteins to change shapes and functions

RAM Medical Corporation L.L.C. (RMC), based in UAE and Germany, has recently set up its headquarters in Dubai. For the past several years, RMC has been developing the next generation of biosensors for biomedical applications. As of October 2022, RMC innovation has created an IP portfolio of more than 60 sensor patents and operates its R&D facilities, cleanrooms, and research labs in Germany. The Company has developed a revolutionary 3D biomolecular mapping platform called ThEA™ (Terahertz Express Analyzer) for real-time 3D imaging of proteins in hopes of radically changing the drug development and personalized diagnostics industries. Continue reading